Efficacy of Parent-child Sleep Intervention
1 other identifier
interventional
306
1 country
1
Brief Summary
Background: Parents of healthy neonates commonly face sleep disruptions and disturbances after delivery. Notably, increasing challenges are evident among parents of ill infants who required clinical care after birth . These challenges can adversely affect psychological adaptation and parental efficacy which consequently impacting the infant's development. It is crucial to develop an effective parent-child sleep intervention for improving parent-infant sleep and mental well-being and uneventful family health outcomes. Aim: To develop and evaluate the effects of parent-child sleep intervention on improving sleep quality, psychological health, and infant health in parents of infants at intermediate care nursery. Methods: A randomized controlled trial will be conducted at the intermediate care nursery of a level III medical center at Taipei city. A total of 102 pairs of parents and infants will be recruited and randomly assigned to the experimental group or the control group. The intervention program consists of (1) parent-child sleep education, (2) heart rate variability biofeedback training, and (3) counseling and support. Data collection will be multiple time points, including baseline, 1 month postpartum, 3 months postpartum, and 6 months postpartum. Anticipated results: Developing and evaluating a parent-child sleep intervention for postpartum parents and their infants. The findings will be an empirical evidence for pediatric care and family health promotion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 16, 2023
CompletedFirst Posted
Study publicly available on registry
November 22, 2023
CompletedStudy Start
First participant enrolled
February 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 24, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 24, 2025
CompletedNovember 18, 2025
November 1, 2025
1.3 years
November 16, 2023
November 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from Baseline in insomnia severity on the Chinese Version of the Insomnia Severity Index (ISI-C) at 1 month postpartum, 3 months postpartum, and 6 months postpartum
The ISI is a validated, self-reported questionnaire assessing insomnia severity over the past month period. Possible scores range from 0 (absence of insomnia) to 28 (severe insomnia).
Baseline, 1 month postpartum, 3 months postpartum, and 6 months postpartum
Secondary Outcomes (8)
Change from Baseline in sleep quality on the Chinese Version of the Pittsburgh sleep quality index (PSQI-C) at 1 month postpartum, 3 months postpartum, and 6 months postpartum
Baseline, 1 month postpartum, 3 months postpartum, and 6 months postpartum
Change from Baseline in infant sleep quality on the Chinese Version of the Brief Infant Sleep Questionnaire-Revised Revised Short Form (BISQ-R-C SF) at 1 month postpartum, 3 months postpartum, and 6 months postpartum
Baseline, 1 month postpartum, 3 months postpartum, and 6 months postpartum
Change from Baseline in anxiety symptoms on the Chinese Version of State-Trait Anxiety Inventory (STAI-C) at 1 month postpartum, 3 months postpartum, and 6 months postpartum
Baseline, 1 month postpartum, 3 months postpartum, and 6 months postpartum
Change from Baseline in parenting efficacy and satisfaction on the Chinese Version of the Parenting Sense of Competence Scale (PSOC-C) at 1 month postpartum, 3 months postpartum, and 6 months postpartum
Baseline, 1 month postpartum, 3 months postpartum, and 6 months postpartum
Infant health outcome
Baseline, 1 month postpartum, 3 months postpartum, and 6 months postpartum
- +3 more secondary outcomes
Study Arms (2)
parent-child sleep intervention
EXPERIMENTALParticipants in the intervention will receive both the standardized usual care and parent-child sleep education, heart rate variability biofeedback training, and counseling and support.
Control
NO INTERVENTIONParticipants in the control group will receive attention from the research nurse and the standardized usual care.
Interventions
The intervention plan is as follows: (1) Parent-child sleep education includes two in-person session and four pre-recorded online sessions. Additionally, it provides educational handbooks tailored to the course content, segmented into sections for both parents and newborns. Each session lasts approximately 20 minutes; (2) Heart rate variability measurement and Heart rate variability biofeedback are conducted in classes in person. It guides parents through breathing exercises to activate the parasympathetic nervous system, thereby easing emotions and improving psychological health; (3) Professional counseling and support are provided separately at two weeks, one month, three months, and six months postpartum.
Eligibility Criteria
You may qualify if:
- Postpartum women aged 18 years or older.
- Postpartum women with a singleton pregnancy, and the gestational age of their infant is at least 32 weeks.
- Postpartum women with a severe insomnia severity index score of ≥8 points.
- Postpartum women and their husbands or partners capable of reading, understanding, and communicating in Mandarin.
- Postpartum women and their husbands or partners with internet access and the ability to operate resources using a smartphone, tablet, or computer.
- Both postpartum women and their husbands or partners are willing to participate in the research process.
You may not qualify if:
- Postpartum women diagnosed with Insomnia Disorder, Anxiety Disorders, or Depression.
- Postpartum women suffering from arrhythmia or cardiovascular diseases.
- Postpartum women working in shifts.
- Infants with congenital abnormalities, neurological impairments (such as hydrocephalus, periventricular leukomalacia), requiring the use of tubes or respirators after discharge, or using medications that might affect sleep (such as caffeine, sedatives, muscle relaxant, anti-epileptic drugs, or pain medications).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Taipei Veterans General Hospital
Taipei, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chien-Hui Chan
Study Principal Investigator
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
November 16, 2023
First Posted
November 22, 2023
Study Start
February 20, 2024
Primary Completion
May 24, 2025
Study Completion
May 24, 2025
Last Updated
November 18, 2025
Record last verified: 2025-11